Vylor (NYSE:VYLR – Get Free Report) has earned a consensus rating of “Moderate Buy” from the twelve research firms that are presently covering the stock, Marketbeat Ratings reports. One research analyst has rated the stock with a sell rating, two have assigned a hold rating, seven have assigned a buy rating and two have issued a strong buy rating on the company. The average 1-year price objective among brokers that have issued ratings on the stock in the last year is $82.00.
VYLR has been the subject of a number of research analyst reports. Zacks Research raised Vylor to a “hold” rating in a research report on Monday, October 5th. Wall Street Zen upgraded Vylor to a “sell” rating in a report on Saturday. BMO Capital Markets assumed coverage on Vylor in a research report on Friday, October 2nd. They set an “outperform” rating and a $85.00 price target on the stock. The Goldman Sachs Group began coverage on Vylor in a research note on Thursday. They set a “buy” rating and a $87.00 price target on the stock. Finally, Wolfe Research upgraded Vylor to a “strong-buy” rating in a research note on Thursday, October 1st.
Read Our Latest Report on VYLR
Vylor Stock Performance
About Vylor
Vylor Inc is a seed and genetics company. It develops and supplies germplasm for farmers to improve crop health and produce higher yields. Vylor Inc is based in JOHNSTON, Iowa.
Further Reading
- Five stocks we like better than Vylor
- 3 Stocks Chopped in Half: Why These Drops May Be Structural, Not a Dip
- Home Depot and Lowe’s Hit 52-Week Lows—But Analysts Aren’t Giving Up
- Utilities Are Bouncing Back—These 2 Giants Could Signal the Next Big Sector Rally
- Q3 Earnings Could Blow Past Consensus—Be Ready for What Comes Next
Receive News & Ratings for Vylor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vylor and related companies with MarketBeat.com's FREE daily email newsletter.
